Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting inflammatory diseases and oncology due to its ability to modulate specific signaling pathways. Its structure allows for selective binding to certain enzyme active sites, enhancing drug efficacy. Commonly employed in research and development of small molecule therapeutics in medicinal chemistry labs and drug discovery programs.